Literature DB >> 12754323

Management of inflammatory neuropathies.

Robert D M Hadden1, Richard A C Hughes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12754323      PMCID： PMC1765628          DOI： 10.1136/jnnp.74.suppl_2.ii9

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

Review 1.  Assessment of current diagnostic criteria for Guillain-Barré syndrome.

Authors:  A K Asbury; D R Cornblath
Journal:  Ann Neurol       Date:  1990       Impact factor: 10.422

Review 2.  Peripheral neuropathies and anti-glycolipid antibodies.

Authors:  Hugh J Willison; Nobuhiro Yuki
Journal:  Brain       Date:  2002-12       Impact factor: 13.501

3.  The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study.

Authors:  B C Jacobs; P H Rothbarth; F G van der Meché; P Herbrink; P I Schmitz; M A de Klerk; P A van Doorn
Journal:  Neurology       Date:  1998-10       Impact factor: 9.910

Review 4.  Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases.

Authors:  J W Griffin; C Y Li; T W Ho; P Xue; C Macko; C Y Gao; C Yang; M Tian; B Mishu; D R Cornblath
Journal:  Brain       Date:  1995-06       Impact factor: 13.501
  4 in total
  5 in total

1.  Axon loss is an important determinant of weakness in multifocal motor neuropathy.

Authors:  J T H Van Asseldonk; L H Van den Berg; S Kalmijn; R M Van den Berg-Vos; C H Polman; J H J Wokke; H Franssen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-06       Impact factor: 10.154

2.  Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy.

Authors:  E A Marsh; C L Hirst; J G Llewelyn; M D Cossburn; M M Reilly; A Krishnan; M Doran; A M Ryan; A J Coles; J L Jones; N P Robertson
Journal:  J Neurol       Date:  2010-01-06       Impact factor: 4.849

3.  Traditional Chinese medicine Yisui Tongjing relieved neural severity in experimental autoimmune neuritis rat model.

Authors:  Erli Zhang; Mingquan Li; Jianjun Zhao; Yuxiang Dong; Xueqin Yang; Jingbo Huang
Journal:  Neuropsychiatr Dis Treat       Date:  2016-09-29       Impact factor: 2.570

4.  Acute paretic syndrome in juvenile White Leghorn chickens resembles late stages of acute inflammatory demyelinating polyneuropathies in humans.

Authors:  Sophie R Bader; Sonja Kothlow; Sascha Trapp; Susanne Cn Schwarz; Hans-Christian Philipp; Steffen Weigend; Ahmad R Sharifi; Rudolf Preisinger; Wolfgang Schmahl; Bernd Kaspers; Kaspar Matiasek
Journal:  J Neuroinflammation       Date:  2010-01-28       Impact factor: 8.322

5.  Dimethyl Fumarate Ameliorates Lewis Rat Experimental Autoimmune Neuritis and Mediates Axonal Protection.

Authors:  Kalliopi Pitarokoili; Björn Ambrosius; Daniela Meyer; Lisa Schrewe; Ralf Gold
Journal:  PLoS One       Date:  2015-11-30       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.